Body-environment Relationship Related Modified Gravity (ENACT)

July 22, 2025 updated by: University Hospital, Caen

Repetitive Gravitationnal Changes on the Body-environment Relationship

The overall objective of this study is to better understand the relationship between the body and its environment, including cognitive performance, following repeated changes in gravity, including microgravity (0G) and modified gravity (i.e., hypergravity (1.8G) and modified gravity (Martian gravity)

Study Overview

Status

Completed

Conditions

Detailed Description

On the eve of the next long voyages into space and the event of space tourism, it becomes more and more urgent to understand how to preserve the health of spacemen (i.e., by profession or by leisure). Extreme and unusual environments, and isolated and confined environments (EUE/ICE) are characterized by unique sensory stimulation. They are known to have negative effects on human psychology, cognitive abilities and physiology, threatening the outcome of space missions or travel. In addition, with the construction of the future Gateway base, the upcoming colonies to Mars and space tourism, travel from one point to another will be much more frequent. These raise new questions that will have to be addressed, whether it is the prolonged duration of a stay in a microgravity environment (i.e., absence of gravitational force between man and his support), in partial gravity and thus the issue of recovery from one trip to the next. These modifications of the environment imply the implementation of several adaptation processes to preserve the homeostatic capacity of the organism. This allows the organism to maintain a relatively stable internal state that persists despite external changes. Nevertheless, many questions remain unanswered. One such question is the impact of repeated changes in gravity during flight to the point of attachment (e.g., colony). The objective of the study is therefore to better understand the relationship between the body and its environment due to repeated changes in gravity, including microgravity.

Beyond that, these results will contribute to enrich the knowledge of this real human challenge that is the question of the adaptation of the human being to the constraints of space travel.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Caen, France, 14033
        • Caen University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Existence of an informed and written consent from the subject
  • Not pregnant
  • No anxiety disorder and/or depression
  • Not to have suffered a head injury
  • Have obtained a medical certificate of aptitude for parabolic flights
  • Be affiliated to the French Social Security, or have a European Health Insurance Card or equivalent

Exclusion Criteria:

  • Pregnant women, parturients and nursing mothers
  • Endocrine pathology (e.g., hyperthyroidism, diabetes)
  • High blood pressure
  • History of head trauma, mood or cardiovascular disorders, cognitive impairment
  • Recent illicit drug use
  • Alcohol dependence
  • Neurological disease and/or history of neurological disease Psychiatric disease and/or history of psychiatric disease
  • Anti-inflammatory treatment
  • Psychotropic treatment
  • Treatments that interfere with heart rate (e.g., beta-blockers, calcium channel blockers, a1 receptor agonists)
  • Persons deprived of liberty, persons hospitalized without consent, persons admitted to a health or social institution for purposes other than research (L-1121-5 to L-1121-8-1)
  • Protected adults, adults unable to express their consent and not subject to a protective measure
  • Participation in other simultaneous trials if this or these protocols concern a pharmacological clinical trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Microgravity condition
a group of parabolic flyers exposed to micro and partial gravity
Cognitive ans sensory performances during repetitive micro and partial gravity exposure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological data
Time Frame: one hour before the flight
Freiburg Mindfulness Inventory questionnaire of 14 items (each item has a score from 1 to 4 i.e. minimal value 14 and maximal value 56, with a couple of reversed item to score)
one hour before the flight
Psychological data
Time Frame: one hour after the flight
Freiburg Mindfulness Inventory questionnaire of 14 items (each item has a score from 1 to 4 i.e. minimal value 14 and maximal value 56, with a couple of reversed item to score)
one hour after the flight
stress
Time Frame: one hour before the flight
Perceived Stress Scale questionnaire: 10 item-questionnaire to perceive stress (each item from 0 to 4: minimal value 0/no stress and maximal value 40 highest stress level)
one hour before the flight
stress
Time Frame: one hour after the flight
Perceived Stress Scale questionnaire: 10 item-questionnaire to perceive stress (each item from 0 to 4: minimal value 0/no stress and maximal value 40 highest stress level)
one hour after the flight
Cognition
Time Frame: one hour before the flight
Cognitive test battery questionnaire, 2D and 3D testing during one session: three scores ponderated (each with 6 plots represented with a spider graph measuring the surface from arbitrary unit)
one hour before the flight
Cognition
Time Frame: one hour after the flight
Cognitive test battery questionnaire, 2D and 3D testing during one session: three scores ponderated (each with 6 plots represented with a spider graph measuring the surface from arbitrary unit)
one hour after the flight
Olfaction
Time Frame: one hour before the flight
Olfactive discrimination test
one hour before the flight
Olfaction
Time Frame: one hour after the flight
Olfactive discrimination test
one hour after the flight
Posture
Time Frame: one hour before the flight
Ellipse of the center of gravity measurment
one hour before the flight
Posture
Time Frame: one hour after the flight
Ellipse of the center of gravity measurment
one hour after the flight
Physiological data
Time Frame: Continuous recording all along microgravity exposure up to 1hour after the end of the flight
Heart Rate variability
Continuous recording all along microgravity exposure up to 1hour after the end of the flight

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 23, 2022

Primary Completion (Actual)

April 26, 2023

Study Completion (Actual)

December 23, 2023

Study Registration Dates

First Submitted

August 30, 2022

First Submitted That Met QC Criteria

September 5, 2022

First Posted (Actual)

September 7, 2022

Study Record Updates

Last Update Posted (Actual)

July 25, 2025

Last Update Submitted That Met QC Criteria

July 22, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Body Schema

Clinical Trials on Cognition and emotional neuropsychologicl evaluations

Subscribe